AFT Pharmaceuticals Limited

NZ$4.60As of Sun 8 Nov 2026, 12:00 UTC
NZX:AFTHealthcare
Country New Zealand
PE (Fwd) •••
TSR 10Y CAGR 4.36%
Div yield 0.54%
ROE 13.66%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.52
PE TTM 32.86
TSR TTM 50.50%
Mkt cap NZ$482.4M
ROIC 10.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.63
0.66%
(89.15%)
Hold 12|5|8|0|11
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.05
0.05
0.05
0.06
10.41%
22.32%
21.07%
32.40%
Revenue$M
30.63
31.56
32.63
34.43
3.59%
3.64%
7.94%
13.00%
Peers (US$267.6M)
Cap (US$)
PE
152.0M
13.45x
17.74M
50.00x
Capital
TTM
5Y
10Y
Leveragex
1.180
0.245
0.241
EBIT/Intx
4.158
0.135
0.105
Own earn%
18.35
(93.26)
(81.63)
Sh yield%
35.37
37.55
42.35
Owners
Insiders/Inst%
12.68
48.16
Short interest%
3.43
SBC / revenue%
0.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
2–12
$1 testx
—
Incr. ROIC%
4